Stevanato Group S.p.A (STVN) Capital Expenditures Growth (1y) (2021 - 2026)
Stevanato Group S.p.A (STVN) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.02 Bn | 120.80 Bn | 1.96 Bn | 17.46% |
| 2 | Becton Dickinson | 44.98 Bn | 44.16 Bn | 2.15 Bn | 9.65% |
| 3 | Alcon | 33.07 Bn | 31.41 Bn | 1.53 Bn | - |
| 4 | Medline | 33.03 Bn | 30.80 Bn | 1.84 Bn | -2.04% |
| 5 | Resmed | 29.47 Bn | 27.81 Bn | 890.98 Mn | 61.83% |
| 6 | West Pharmaceutical Services | 23.28 Bn | 22.84 Bn | 329.20 Mn | -42.55% |
| 7 | Solventum | 14.06 Bn | 13.50 Bn | 1.10 Bn | -22.94% |
| 8 | Cooper Companies | 13.93 Bn | 13.79 Bn | 735.40 Mn | 10.63% |
| 9 | Align Technology | 12.10 Bn | 11.04 Bn | 736.59 Mn | 21.73% |
| 10 | Stevanato Group S.p.A | 5.43 Bn | 5.28 Bn | 88.01 Mn | -4.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.77% |
| Dec 31, 2025 | -9.42% |
| Sep 30, 2025 | -11.11% |
| Jun 30, 2025 | 11.88% |
| Mar 31, 2025 | 32.21% |
| Dec 31, 2024 | -7.67% |
| Sep 30, 2024 | 65.84% |
| Jun 30, 2024 | 26.29% |
| Mar 31, 2024 | 20.34% |
| Dec 31, 2023 | -27.36% |
| Sep 30, 2023 | -250.89% |
| Jun 30, 2023 | -27.15% |
| Mar 31, 2023 | -131.61% |
| Dec 31, 2022 | -66.82% |
| Sep 30, 2022 | -26.49% |
| Jun 30, 2022 | -194.03% |
| Mar 31, 2022 | -125.84% |
| Dec 31, 2021 | -20.93% |
| Sep 30, 2021 | -42.04% |
| Jun 30, 2021 | -1.29% |